. Author manuscript; available in PMC: 2009 Nov 1.

Published in final edited form as: J Immunol. 2009 May 1;182(9):5203–5207. doi: 10.4049/jimmunol.0804243

Table:I.

CD59 expression on CD4⁺ T cells

	Unstimulated		Anti-CD3+CD28		PPD
	% of cells	CD59 (MFI)	% of cells	CD59 (MFI)	% of cells	CD59 (MFI)
CD4⁺CD69⁻	98.44	225	63.88	229	92.4	222
CD4⁺CD69⁺	1.31	336	35.05	346	7.03	386
CD4⁺CD25⁻	73.73	225	50.24	209	72.20	217
CD4⁺CD25^med	22.55	290	21.14	279	18.28	296
CD4⁺CD25^high	1.24	330	26.89	406	6.69	309
CD4⁺FoxP3⁻	93.29	223	75.25	235	87.01	226
CD4⁺FoxP3⁺	6.69	285	24.74	382	12.38	296
CD4⁺CTLA4⁻	98.1	225	78.98	241	94.85	222
CD4⁺CTLA4⁺	1.02	330	18.69	362	3.97	342

PBMCs were either left unstimulated or stimulated with anti-CD3+CD28 beads or PPD. The percentage of cells within each subset is shown as well as the MFI of CD59 on each subset. Values are representative of four independent experiments performed using blood obtained from different individuals